Market Overview The global Biosimilars Market is experiencing explosive growth driven by immunology biosimilar availability, autoimmune disease management evolution, and anti-TNF therapy cost reduction. The global biosimilars market is projected to exceed USD 30 billion through 2030, fueled by adalimumab biosimilar launch, etanercept biosimilar growth, and infliximab biosimilar expansion....
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek